Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Resist Updat. 2004 Aug-Oct;7(4-5):257-66.

Leishmaniasis: drugs in the clinic, resistance and new developments.

Author information

1
Centre de Recherche en Infectiologie du Centre de Recherche du CHUL and Division de Microbiologie, Faculté de Médecine, Université Laval, Que., Canada G1V 4G2. marc.ouellette@crchul.ulaval.ca

Abstract

The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available for treating Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, fluconazole and few other drugs at various stages of their development process. In this review, we will discuss the latest results regarding resistance mechanisms to drugs used in the clinic against Leishmania infections.

PMID:
15533763
DOI:
10.1016/j.drup.2004.07.002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center